Publications by authors named "Simon Loiodice"

Claim this Profile
N
Neuropsychiatric drug development: Perspectives on the current landscape, opportunities and potential future directions.
Simon Loiodice, Fulvio D'Acquisto, Pim Drinkenburg, Christian Suojanen, Pierre-Michel Llorca

Drug Discov Today· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study.
Simon Loiodice, Wilhelmus H Drinkenburg, Abdallah Ahnaou, Andrew McCarthy, Geoffrey Viardot

Transl Psychiatry· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mismatch negativity as EEG biomarker supporting CNS drug development: a transnosographic and translational study.
Simon Loiodice, Wilhelmus H Drinkenburg, Abdallah Ahnaou, Andrew McCarthy, Geoffrey Viardot

Transl Psychiatry· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current trends in in silico, in vitro toxicology, and safety biomarkers in early drug development.
Simon Loiodice, Andre Nogueira da Costa, Franck Atienzar

Drug Chem Toxicol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implication of nigral dopaminergic lesion and repeated L-dopa exposure in neuropsychiatric symptoms of Parkinson's disease.
Simon Loiodice, Harry Wing Young, Bertrand Rion, Benoît Méot, Pierre Montagne

Behav Brain Res· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a New Scoring Scale for Behavioral Assessment of L-Dopa-Induced Dyskinesia in the Rat: A New Tool for Early Decision-Making in Drug Development.
Simon Loiodice, Anne-Sophie Denibaud, Wendy Deffains, Magali Alix, Pierre Montagne

ACS Chem Neurosci· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's disease.
Simon Loiodice, Portia McGhan, Vitalina Gryshkova, Renaud Fleurance, David Dardou

J Psychopharmacol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pramipexole induced place preference after L-dopa therapy and nigral dopaminergic loss: linking behavior to transcriptional modifications.
Simon Loiodice, Poppy Winlow, Sarah Dremier, Etienne Hanon, David Dardou

Psychopharmacology (Berl)· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis